Publicacións en colaboración con investigadores/as de Centro de Investigación Biomédica en Red de Cáncer (27)

2024

  1. Genome-wide DNA methylation profiling in tongue squamous cell carcinoma

    Oral Diseases, Vol. 30, Núm. 2, pp. 259-271

2023

  1. Clinical, molecular, and immune correlates of the Immunotherapy Response Score in patients with advanced urothelial carcinoma under atezolizumab monotherapy: analysis of the phase II IMvigor210 trial

    ESMO Open, Vol. 8, Núm. 4

  2. Effect of capmatinib on the pharmacokinetics of substrates of CYP3A (midazolam) and CYP1A2 (caffeine) in patients with MET-dysregulated solid tumours

    British Journal of Clinical Pharmacology, Vol. 89, Núm. 3, pp. 1046-1055

  3. Effectiveness of a novel gene nanotherapy based on putrescine for cancer treatment

    Biomaterials Science, Vol. 11, Núm. 12, pp. 4210-4225

  4. Erratum: Effectiveness of a novel gene nanotherapy based on putrescine for cancer treatment (Biomaterials Science (2023) DOI: 10.1039/d2bm01456d

    Biomaterials Science

  5. MSIMEP: Predicting microsatellite instability from microarray DNA methylation tumor profiles

    iScience, Vol. 26, Núm. 3

  6. Modelling metastasis in zebrafish unveils regulatory interactions of cancer-associated fibroblasts with circulating tumour cells

    Frontiers in Cell and Developmental Biology, Vol. 11

  7. Noninvasive detection of microsatellite instability in patients with endometrial cancer

    International Journal of Cancer, Vol. 152, Núm. 10, pp. 2206-2217

  8. PEGylation Effects on the Interaction of Sphingomyelin Nanoemulsions with Serum Albumin: A Thermodynamic Investigation

    Macromolecular Materials and Engineering, Vol. 308, Núm. 6

  9. Somatic mutations in tumor and plasma of locoregional recurrent and/or metastatic head and neck cancer using a next-generation sequencing panel: A preliminary study

    Cancer Medicine, Vol. 12, Núm. 6, pp. 6615-6622

2022

  1. A genome-wide cell-free DNA methylation analysis identifies an episignature associated with metastatic luminal B breast cancer

    Frontiers in Cell and Developmental Biology, Vol. 10

  2. Clinical significance of baseline Pan-Immune-Inflammation Value and its dynamics in metastatic colorectal cancer patients under first-line chemotherapy

    Scientific Reports, Vol. 12, Núm. 1

  3. Improving the Management of Endometrial Cancer Patients through the Use of Liquid Biopsy Analyses: A Case Report

    International Journal of Molecular Sciences, Vol. 23, Núm. 15

  4. Integrating digital pathology with transcriptomic and epigenomic tools for predicting metastatic uterine tumor aggressiveness

    Frontiers in Cell and Developmental Biology, Vol. 10

  5. Integrity and quantity of salivary cell-free DNA as a potential molecular biomarker in oral cancer: A preliminary study

    Journal of Oral Pathology and Medicine, Vol. 51, Núm. 5, pp. 429-435

  6. Noninvasive early detection of colorectal cancer by hypermethylation of the LINC00473 promoter in plasma cell-free DNA

    Clinical Epigenetics, Vol. 14, Núm. 1

  7. Peptide-Functionalized Nanoemulsions as a Promising Tool for Isolation and Ex Vivo Culture of Circulating Tumor Cells

    Bioengineering, Vol. 9, Núm. 8

  8. Plasma cell-free DNA and circulating tumor cells as prognostic biomarkers in small cell lung cancer patients

    Translational Lung Cancer Research, Vol. 11, Núm. 10, pp. 1995-2009

  9. Red Blood Cells Protein Profile Is Modified in Breast Cancer Patients

    Molecular and Cellular Proteomics, Vol. 21, Núm. 12

2021

  1. Current status and future perspectives of liquid biopsy in small cell lung cancer

    Biomedicines, Vol. 9, Núm. 1, pp. 1-22